Paper40301429
Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer.
Li B and 8 others. Sci Rep, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer. Papers, record 40301429. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40301429
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Correlation study of PBK/TOPK expression, prognosis, and immune infiltration in breast cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Lymphocytes, Tumor-Infiltrating | Major topic |
| Humans | |
| Female | |
| Prognosis | |
| Biomarkers, Tumor | |
| Gene Expression Regulation, Neoplastic | |
| Middle Aged | |
| CD8-Positive T-Lymphocytes | |
| Kaplan-Meier Estimate | |
| Mitogen-Activated Protein Kinase Kinases |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| LJKMZ20221847 | Department of Education of Liaoning Province | LJKMZ202218 | PubMed | NIH RePORTER | |
| 320.6750.2022-19-83 | Wu Jieping Medical Foundation | PubMed | PubMed |
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21996732 | TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer. | Oncogene | 2012 | https://conductscience.org/library/papers/21996732 | PubMed |
| 2 | 17545598 | T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation. | Cancer Res | 2007 | https://conductscience.org/library/papers/17545598 | PubMed |
| 3 | 10781613 | Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10781613 | PubMed |
| 4 | 28525379 | PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/28525379 | PubMed |
| 5 | 28333152 | Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28333152 | PubMed |
| 6 | 12453469 | Regulation of growth-related genes by interleukin-6 in murine myeloma cells. | Cytokine | 2002 | https://conductscience.org/library/papers/12453469 | PubMed |
| 7 | 32442275 | TIMER2.0 for analysis of tumor-infiltrating immune cells. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/32442275 | PubMed |
| 8 | 31757421 | TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling. | Biochem Biophys Res Commun | 2020 | https://conductscience.org/library/papers/31757421 | PubMed |
| 9 | 30656832 | MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway. | Cancer Med | 2019 | https://conductscience.org/library/papers/30656832 | PubMed |
| 10 | 31510660 | Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. | Bioinformatics | 2019 | https://conductscience.org/library/papers/31510660 | PubMed |
| 11 | 19900192 | Critical roles of T-LAK cell-originated protein kinase in cytokinesis. | Cancer Sci | 2010 | https://conductscience.org/library/papers/19900192 | PubMed |
| 12 | 24629784 | Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma. | Immunobiology | 2014 | https://conductscience.org/library/papers/24629784 | PubMed |
| 13 | 36923407 | Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer. | Front Immunol | 2023 | https://conductscience.org/library/papers/36923407 | PubMed |
| 14 | 29092952 | TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Cancer Res | 2017 | https://conductscience.org/library/papers/29092952 | PubMed |
| 15 | 31708778 | Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31708778 | PubMed |
| 16 | 36717668 | Mechanisms driving the immunoregulatory function of cancer cells. | Nat Rev Cancer | 2023 | https://conductscience.org/library/papers/36717668 | PubMed |
| 17 | 36171591 | Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis. | World J Surg Oncol | 2022 | https://conductscience.org/library/papers/36171591 | PubMed |
| 18 | 33599248 | bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. | Database (Oxford) | 2021 | https://conductscience.org/library/papers/33599248 | PubMed |
| 19 | 33435254 | Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33435254 | PubMed |
| 20 | 32361569 | Breast cancer: Biology, biomarkers, and treatments. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/32361569 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941908 | Co-Regulation Analysis of Domain-Specific Phosphosites Reveals Insights into the Phosphoregulation-Directed Functional Diversity of Nucleolin. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941908 | PubMed |
| 42724446 | PDZ-binding kinase promotes ovarian cancer cell proliferation and invasion via CCNB1 regulation. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724446 | PubMed |
| 42351867 | Artificial Intelligence-Driven Construction of Predictive and Druggable Frameworks to an In Silico Bioengineering Evidence Support for Therapy of Esophageal Squamous Cell Carcinoma Patients: Insights from a Toll-like Receptor Signal with Th17 and T Helper Microenvironment. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42351867 | PubMed |
| 42277369 | Elevated Plasma T-LAK cell-originated protein kinase Owned the Potential for Predicting Favorable Outcomes in Acute Ischemic Stroke Patients. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42277369 | PubMed |
| 42237026 | Targeting the TOPK-STAT3 pathway in keratinocytes and mast cells mediates the therapeutic attenuation of Atopic dermatitis. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42237026 | PubMed |
| 42079338 | Advances in T-Lymphokine-activated Killer Cell-originated Protein Kinase Research in Cancer Over the Past Thirty Years. | J Cancer Prev | 2026 | https://conductscience.org/library/papers/42079338 | PubMed |
| 41139451 | [PDZ-binding kinase as a prognostic biomarker for pancreatic cancer: a pan-cancer analysis and validation in pancreatic adenocarcinoma cells]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | https://conductscience.org/library/papers/41139451 | PubMed |
| 40822625 | RBM15 aggravates endometrial cancer progression by inducing PBK m6A modification to inhibit the p53 pathway. | Cytotechnology | 2025 | https://conductscience.org/library/papers/40822625 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| PBK | 55872 | PubTator's text mining | https://conductscience.org/library/genes/55872 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40301429
GET https://conductscience.org/api/papers/v1/40301429/references?page=2